Thanks - the company is Cynata ASX CYP but a long long way back in terms of where it is at. Have a phase 1 trial with preliminary results that are positive as you would expect. But a long long way to go. Mesoblast is going to beat it to market by many, many years that is if Cynata ever gets it there.
Cheers
Thanks - the company is Cynata ASX CYP but a long long way back...
Add to My Watchlist
What is My Watchlist?
